A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19

Bibliographic Details
Main Authors:	Gebhard Wagener, Monica P. Goldklang, Adam Gerber, Katerina Elisman, Katherine A. Eiseman, Laura D. Fonseca, Jeanine M. D’Armiento
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Series:	Critical Care
Online Access:	https://doi.org/10.1186/s13054-022-04096-9

Internet